
Announced 1 October 2026
ZEISS MyoActive
Tiny treatment lenses of varying power in offset rings. One year of ZEISS data; year two due in 2027. Available here now.
Photo: ZEISS
Myopia control glasses compared · Sydney
We fit Stellest 2.0 and MiyoSmart iQ.
ZEISS MyoActive now available.

The quick answer
Each slowed average axial length progression compared with ordinary glasses in its maker's trial. No trial has compared them directly.

Stellest 2.0
Essilor
Rings of tiny treatment lenses. Two-year published results (original design).
$690per pair

MiyoSmart iQ
HOYA
Honeycomb segments. Based on the design with the longest follow-up.
$750per pair, Spark coating included

ZEISS MyoActive
ZEISS · announced 1 Oct 2026
Varied tiny treatment lenses. One year of company data.
$690per pair
Lens photos: Essilor, HOYA, ZEISS.
We recommend what suits your child, and your optometrist must decide which lens is appropriate. Switching later is straightforward.
At a glance
Six common parent questions.
How it works
Stellest 2.0
Rings of tiny, non-spherical treatment lenses
H.A.L.T. · 12 rings in the 2.0 design
MiyoSmart iQ
Honeycomb of light-focusing segments
D.I.M.S. · smaller clear centre than the original
ZEISS MyoActive
Tiny treatment lenses with varying power
M.O.V.E. · deliberately offset rings
Published results
Stellest 2.0
2 years, independently reviewed (original design)
plus 5-year follow-up
MiyoSmart iQ
2 years, independently reviewed (original design)
iQ: 1 year, conference only
ZEISS MyoActive
1 year, company data
not yet published
In Australia since
Stellest 2.0
2022
2.0 rolling out 2026
MiyoSmart iQ
August 2026
original MiyoSmart since 2020
ZEISS MyoActive
Announced 1 October 2026
Available here now
Darkens outdoors?
Stellest 2.0
No
MiyoSmart iQ
Yes, MiyoSmart Chameleon
original design, $690
ZEISS MyoActive
No
Lens material
Stellest 2.0
1.59 polycarbonate
MiyoSmart iQ
1.59 polycarbonate
ZEISS MyoActive
1.59 polycarbonate
ZEISS MyoCare offers 1.5 to 1.67
Our price
Stellest 2.0
$690 per pair
MiyoSmart iQ
$750 per pair
Spark coating, 12-month scratch warranty
ZEISS MyoActive
$690 per pair
Two-year results: Lam et al. 2020 (MiyoSmart), Bao et al. 2022 (Stellest). MyoActive: ZEISS one-year data, Shanghai trial, submitted for publication.
First lens
Starting points only. We measure your child, then decide with you.
Longest research follow-up
MiyoSmart iQ
Based on DIMS, with six years of published follow-up.
Eyes worsening quickly or outgrowing an earlier lens
Stellest 2.0 or MiyoSmart iQ
Both newer designs have a smaller clear centre and stronger signal.
Difficulty adjusting to a previous lens
ZEISS MyoActive
Newest design. One year of company data. ZEISS reports adjustment similar to ordinary glasses.
Strong prescription, over −5.00
ZEISS MyoCare 1.67
The only thinner-material option. Two-year published results.
In our practice
Some children find MiyoSmart iQ harder to adjust to because vision away from the centre looks softer. One child we fitted found piano music hard to read in them. Children have found the ZEISS designs we fit easier to adjust to. We weigh this experience alongside each lens's research.

MiyoSmart Chameleon is original MiyoSmart that darkens outdoors. Some children using atropine prefer this because the drops increase light sensitivity. Others dislike the outdoor tint, which cannot be switched off. We no longer recommend it by default. $690, no surcharge.
How we choose
MiyoSmart and Stellest have published trials on their earlier designs. ZEISS MyoActive has company data only. No trial has compared them directly. Which one suits your child comes down to their prescription, how fast their eyes are growing, and what they will wear all day. Those are things we measure, not things anyone can tell from a page.
A glasses prescription measures refraction. Refraction fluctuates with focusing effort, especially in children. Axial length doesn't. We measure it here on the Zeiss IOLMaster 500 optical biometer: a brief flash of infrared light, about 30 seconds per eye. The scan itself needs no drops and never touches the eye. Axial length is what myopia control treatment sets out to slow. How axial length works
SightTrack™ The SightTrack chart: a child's axial length, tracked against age
Sample · illustrative
A child's eye, review by review · Typical range for age · Fast for age
Reference curves: Ulster / NICER axial-length growth charts (McCullough et al., 2020). Sample data (not a real patient, not a treatment result), shown to illustrate how we track.
Children's Myopia Assessment: $95. Prefer to read more first? See what happens at the assessment
You're not locked in. If the first lens turns out not to suit your child, switching to one of the others is straightforward. We fit MiyoSmart, Stellest and ZEISS lenses, so the recommendation is about your child, not about what we happen to stock.

Dr Mark Joung, Principal Optometrist
Fits MiyoSmart, Stellest and ZEISS lenses · one of the first optometrists in Australia to fit MiyoSmart, both the original and MiyoSmart iQ
How each lens works
All three correct vision through the centre like ordinary glasses. Each brand slows myopia around it with its own design.
D.I.M.S.
Around a clear centre (6.9 mm on MiyoSmart iQ, 9.4 mm on the original), MiyoSmart places hundreds of tiny defocus segments in a honeycomb pattern. Each segment creates a controlled blur that signals the eye to slow its growth.
For your child: central vision as sharp as ordinary glasses. Most children settle in; some take longer.
H.A.L.T.
Stellest places twelve concentric rings of tiny aspherical lenslets around the central clear zone. Rather than creating a single focal point, they create a "volume" of out-of-focus light in front of the retina.
For your child: the lenslets are very subtle, and most people don't notice them.
M.O.V.E.
Around a 7 mm clear centre, MyoActive places small lenslets of varying power in concentric rings out to the edge of the lens. The lenslets are deliberately misaligned from ring to ring, so the eye meets a changing pattern as it moves.
For your child: ZEISS reports that most children adapted within a week, the same as ordinary glasses.
Drawn to scale on a 70 mm lens from published figures (HOYA, Essilor; ZEISS MyoActive white paper, September 2026). *Stellest 2.0's clear zone is not published, so it is drawn at the original's 9 mm, outer reach estimated.
What the research shows
All three work. MiyoSmart has the longest record, not a lasting lead; newer designs build on the same principle.
MiyoSmart
HOYA · the DIMS design
2 yrs
randomised trial, independently reviewed (2020)
6 yrs
longest published follow-up
Independently reviewed
No faster worsening reported after stopping. MiyoSmart iQ builds on this evidence and is expected to work at least as well; how much it adds is still being studied.
Stellest
Essilor
2 yrs
randomised trial, independently reviewed (2022)
5 yrs
longest published follow-up
Independently reviewed
US FDA-authorised in 2025. Stellest 2.0 builds on this design; its first results compare it with the original Stellest.
ZEISS MyoActive
ZEISS
1 yr
company trial, not yet published
None
no long-term follow-up yet
Company data
Launched October 2026. Year-two results expected in 2027.
No trial has compared them directly. All-day wear matters more than brand.
MiyoSmart. The 2020 trial studied Chinese children aged 8 to 13. The six-year study found lasting slowing and no faster worsening after stopping. UK and European studies observed existing care without randomly assigning treatment.
Stellest. Two-year trials studied Chinese children and a diverse US group. The five-year follow-up uses estimated comparison results; an ongoing control group is absent.
ZEISS MyoActive. One Shanghai trial compared five ZEISS designs with ordinary glasses in 342 children aged 7 to 13. MyoActive performed best of the five. ZEISS reports adjustment similar to ordinary glasses. No results after stopping yet.
Earlier ZEISS MyoCare has two-year, independently reviewed trials in China and Europe.
ZEISS MyoCare
MyoCare is the earlier ZEISS design and the thinner choice for strong prescriptions.
Sources: ZEISS (2026); Chen et al., 2025; Alvarez-Peregrina et al., 2026.
Already in MyoCare and stable? ZEISS advises staying in it when the prescription changed by less than 0.25 D in 12 months. We check this at each review.
Looks and thickness
From the front, they look like ordinary glasses.
Straight ahead
The clear centre looks and works like an ordinary lens.
Up close
The tiny treatment lenses are subtle. Most people don't notice them.
Thickness
Most designs are 1.59 polycarbonate. Above −5.00, MyoCare 1.67 is thinner.
Frame height
The frame must be tall enough for the treatment zone. We check it.
New in 2026

Announced 1 October 2026
Tiny treatment lenses of varying power in offset rings. One year of ZEISS data; year two due in 2027. Available here now.
Photo: ZEISS

In Australia since August 2026
Smaller clear centre and stronger signal than the original. One year of HOYA data. About MiyoSmart iQ
Photo: HOYA
Stellest 2.0 increases treatment rings from 11 to 12 and uses higher-powered tiny treatment lenses. Early data compare it with original Stellest; an ordinary-glasses comparison is absent.
Smaller clear centres in newer designs need precise pupil distance and height measurements. Small fitting errors shift the treatment out of position.
HOYA's new Smooth Touch Xtreme coating is designed to keep MiyoSmart clean through years of children's wear. It changes durability; treatment stays the same.
Photochromic option
Of the lenses on this page, only MiyoSmart has a photochromic version available in Australia. The lens darkens outdoors and clears indoors, so your child doesn't have to swap between clear glasses and sunglasses.
It uses the same DIMS technology underneath, with a photochromic film added. 100% UV protection even when the lens is clear. Fades back to clear within about a minute when your child comes back inside.
A practical pairing with atropine drops: if your child is on low-dose atropine for myopia control, the drops dilate the pupil slightly and cause light sensitivity. Chameleon photochromic lenses reduce that glare automatically, which makes combination therapy more comfortable day-to-day.
For an iQ version of Chameleon, ask us about availability. The current Chameleon remains the photochromic option, at $690, the same as Stellest 2.0, with no photochromic surcharge.
For kids who spend a lot of time outdoors · Reduces glare for children on atropine drops · $690, no photochromic surcharge
Pricing
Written quote before ordering.
MiyoSmart iQ
$750
per pair
Includes Spark coating and 12-month scratch warranty
A free remake if the prescription changes by 0.50 D or more within 12 months. After that, a prescription change or a scratched lens means a new pair at full price.
ZEISS MyoActive
$690
per pair
Available here now
ZEISS replaces the lenses if your child's prescription increases by 0.50 D or more within 18 months.
Stellest 2.0
$690
per pair
Existing Stellest wearers continue at $600
We remake them free if the prescription changes within the first 12 months.
Claim health fund extras rebates here. ZEISS MyoCare prices depend on lens material index.
Not sure which lens?
We measure your child's axial length, then recommend the option that suits them.
Pros and cons by lens
All three work. These are the practical differences we discuss with parents.
For
Against
For
Against
For
Against
How we decide
Every option here slows myopia in clinical trials. Daily life decides which suits your child.
Age
Is your child 6 or older?
If the answer is No
MiyoSmart iQ, Stellest 2.0, ZEISS MyoActive
Worn every waking hour. The frame has to fit well and stay put.
If the answer is Yes
Contact lenses
Is your child open to contact lenses?
If the answer is No
MiyoSmart iQ, Stellest 2.0, ZEISS MyoActive
Worn every waking hour. The frame has to fit well and stay put.
If the answer is Yes
Worn overnight, out in the morning
Parents run it at home, about five minutes night and morning. Nothing to wear during the day.
A fresh lens each morning
Worn through the school day. Your child takes it out on their own if it bothers them.
Whichever you choose:
If your child's eyes keep getting worse despite consistent wear, your optometrist may add atropine drops or move your child to another option.
We measure axial length (the length of the eye) with a ZEISS IOLMaster 500 at the start and every six months. This checks treatment effect alongside how well the glasses focus. Our myopia control approach
Frequently asked questions
What we get asked at the consultation.
In their makers' trials, each slowed axial length progression on average compared with ordinary glasses. No trial has compared them directly. Wearing them consistently and fitting them well matter more than the brand. We recommend the best option for your child at the consultation.
It depends on your child. The original Stellest has a two-year published trial (Bao et al., 2022), a five-year follow-up (Li et al., 2025) and US FDA authorisation (2025); Stellest 2.0 builds on that design. Like every lens here, it works when worn all day and fitted precisely. Stellest 2.0 is $690 a pair; we explain at the assessment whether it or another lens suits your child better.
Yes. Combining myopia control glasses with low-dose atropine drops can add further benefit when the eyes are getting worse quickly. Some children on atropine prefer MiyoSmart Chameleon, which darkens outdoors; we discuss it at the fitting. Dr Mark Joung is therapeutically endorsed and can prescribe atropine directly.
No. The myopia control technology sits outside the central viewing zone, so when your child looks ahead the vision is as clear as ordinary glasses. The lenslets and microstructures are very subtle — most people don't notice them. For higher prescriptions above –5.00 D, MyoCare is available in a thinner 1.67 index material.
Most children benefit through to their late teens, when axial length progression typically stabilises. We track axial length at every six-month review so we can see when it slows naturally.
The 6-year MiyoSmart data found no rebound: in children who stopped, the eyes did not get worse faster than they would have without ever wearing the lenses. Data for Stellest and MyoCare after discontinuation is more limited, which is one of the things we discuss with you.
Yes. We can move your child between lenses if the first choice isn't slowing axial length progression as much as we want to see. Because we fit more than one brand, we're not locked into defending one if another suits your child better.
Myopia control lenses start from $690 per pair. Stellest 2.0 and MiyoSmart Chameleon photochromic are $690 (no surcharge for Chameleon). MiyoSmart iQ is $750 per pair, which includes the Spark coating with a 12-month scratch warranty. MyoCare varies by index. Frames are separate — children's frames from $150, and Tomato Glasses, built to hold myopia-control lenses in the right position, are $210. Getting started is the Children’s Myopia Assessment — $95 out of pocket, with axial-length measurement included. Once your child is in the program, six-monthly review scans are $45. Private health fund optical extras rebates apply. We give you a full written quote before ordering.
We review your child every six months with an axial length measurement and refraction check. If the prescription changes by 0.50 dioptres or more within the warranty period, the lenses are replaced under the manufacturer warranty — terms vary by brand.

Reviewed by Dr Mark Joung, B.Optom (Hons) UNSW
Mark is the principal optometrist at Concord Eyecare and one of the first optometrists in Australia to fit MiyoSmart, both the original and MiyoSmart iQ. He fits MiyoSmart, Stellest and ZEISS MyoCare myopia control lenses and prescribes low-dose atropine drops directly.
The 2,500+ and 1,000+ figures come from our optometrists' practice records across their careers (October 2026).
Concord Eyecare serves families from across Sydney for myopia control, from the Inner West, North Shore, Eastern Suburbs and beyond.